Theralase Technologies Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was CAD 0.136813 million compared to CAD 0.234021 million a year ago. Net loss was CAD 1.07 million compared to CAD 1.45 million a year ago. Basic loss per share from continuing operations was CAD 0.005 compared to CAD 0.007 a year ago. For the nine months, sales was CAD 0.566812 million compared to CAD 0.527474 million a year ago. Net loss was CAD 3.13 million compared to CAD 4.72 million a year ago. Basic loss per share from continuing operations was CAD 0.015 compared to CAD 0.02 a year ago.